S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Become an Investor in Brooklyn Gin (Ad)pixel
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Become an Investor in Brooklyn Gin (Ad)pixel
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Become an Investor in Brooklyn Gin (Ad)pixel
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Become an Investor in Brooklyn Gin (Ad)pixel
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
LON:INDV

Indivior - INDV Share Forecast, Price & News

GBX 1,961
+6.00 (+0.31%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
1,915
1,973
50-Day Range
1,685
2,015.33
52-Week Range
1,052
2,020
Volume
179,549 shs
Average Volume
357,916 shs
Market Capitalization
£2.68 billion
P/E Ratio
8,913.64
Dividend Yield
N/A
Price Target
GBX 330

INDV stock logo

About Indivior (LON:INDV) Stock

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INDV Stock News Headlines

Indivior (LON:INDV) Reaches New 1-Year High at $1,999.00
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Indivior To Acquire Opiant Pharmaceuticals
Indivior Announces Q3 2022 Financial Results
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Indivior Announces H1 and Q2 2022 Financial Results
See More Headlines
Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INDV Company Calendar

Today
1/31/2023
Next Earnings (Estimated)
2/14/2023

Industry, Sector and Symbol

Industry
Drugs - Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
885
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 330
High Stock Price Forecast
GBX 330
Low Stock Price Forecast
GBX 330
Forecasted Upside/Downside
-83.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£882 million
Cash Flow
GBX 731.69 per share
Book Value
GBX 164.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.68 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Mark Crossley
    CEO & Exec. Director
  • Mr. Ryan Preblick
    CFO & Exec. Director
  • Dr. Christian Heidbreder
    Chief Scientific Officer
  • Mr. Jason Thompson
    VP of Investor Relations
  • Ms. Cynthia Cetani
    Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris (Age 51)
    Chief Legal Officer
  • Mr. Jon Fogle
    Chief HR Officer
  • Mr. Richard Simkin
    Chief Commercial & Strategy Officer
  • Mr. Hillel West
    Chief Manufacturing & Supply Officer
  • Ms. Nina DeLorenzo
    Chief Global Impact Officer













INDV Stock - Frequently Asked Questions

Should I buy or sell Indivior stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" INDV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INDV, but not buy additional shares or sell existing shares.
View INDV analyst ratings
or view top-rated stocks.

What is Indivior's stock price forecast for 2023?

1 equities research analysts have issued 12-month price objectives for Indivior's shares. Their INDV share price forecasts range from GBX 330 to GBX 330. On average, they anticipate the company's share price to reach GBX 330 in the next twelve months. This suggests that the stock has a possible downside of 83.2%.
View analysts price targets for INDV
or view top-rated stocks among Wall Street analysts.

How have INDV shares performed in 2023?

Indivior's stock was trading at GBX 1,852 at the beginning of the year. Since then, INDV shares have increased by 5.9% and is now trading at GBX 1,961.
View the best growth stocks for 2023 here
.

When is Indivior's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our INDV earnings forecast
.

What other stocks do shareholders of Indivior own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Futura Medical (FUM), Directa Plus (DCTA), Lakehouse (LAKE), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY), Deltex Medical Group (DEMG) and Kingfisher (KGF).

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

How do I buy shares of Indivior?

Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 1,961.

How much money does Indivior make?

Indivior (LON:INDV) has a market capitalization of £2.68 billion and generates £882 million in revenue each year.

How many employees does Indivior have?

The company employs 885 workers across the globe.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The official website for the company is indivior.com. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.

This page (LON:INDV) was last updated on 1/31/2023 by MarketBeat.com Staff